Keywords: genentech, 3rd-qtr, gaap, net, leaps, biotechnology, major

Genentech's 3rd-qtr GAAP net leaps 58%

Article | 16 October 2006

Print This

US biotechnology major Genentech, which is majority owned by Swiss group Roche, has reported a leap of 58% to $568.0 million in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in